Medtech Connect Podcast Episode 7 – Decentralized Clinical Trials

In this episode of Medtech Connect, Medtech Insight spoke to three decentralized clinical trial experts at Hogan Lovells: partner Kristin Zielinski Duggan, partner Blake Wilson and associate Stephanie Agu. We discussed the ins and outs of the draft FDA guidance document, what pieces of the guidance still might need clarification, and how they expect to see the industry change as DCTs become mainstream.

Related resources

A diverse group of people sitting in a waiting room together.
JUL 12, 2023
Patient Engagement & Recruitment

The Need for Clinical Trial Diversity: How We Got Here and Where We're Headed

Clinical trial diversity, the inclusion of underrepresented segments of the population in medical research, is a crucial component of health equity.

PDF preview of the "RWD More than Acronym" article.
OCT 09, 2023

RWD: More Than Just Another Acronym

Real-world data holds the power to impact patient outcomes. Read our article on RWD benefits and how it impacts the patient journey.

Decentralized clinical trials_resource-card-thumbnail
OCT 11, 2023

Decentralized Clinical Trials - Meeting Patients Where They’re At

Decentralized clinical trials are one example of how the research community is working to make trials as accessible as possible.